Bluestar Genomics, UChicago publish whole genome map of key biomarker for detecting cancer

Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to cancer detection, and University of Chicago today announce the publication of a genome-wide 5-hydroxymethylcytosine (5hmC) map across multiple human tissue types. The study, published in the peer-reviewed journal Nature Communications, demonstrated the robust performance of 5hmC as a global biomarker for the…

No nanoparticle risks to humans found in field tests of spray sunscreens

People can continue using mineral-based aerosol sunscreens without fear of exposure to dangerous levels of nanoparticles or other respirable particulates, according to Penn State research published in the journal Aerosol Science and Engineering. The findings, reported by a research team led by Jeremy Gernand, associate professor of industrial health and safety, are a result of…

Who Will Get the Coronavirus Vaccine First?

After months of deliberation and debate, a panel of independent experts advising the Centers for Disease Control and Prevention is set to decide on Tuesday which Americans it will recommend to get the coronavirus vaccine first, while supply is still short. The panel, the Advisory Committee on Immunization Practices, will vote in a public meeting…